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Ascorbic acid serves a vital role as a pre-eminent antioxidant. In animals, it has been shown to be
concentrated in granulosa and theca cells of the follicle, in luteal cells of the corpus luteum, and in the
peripheral cytoplasm of the oocyte. We have previously identified hormonally-regulated ascorbic acid
transporters in rat granulosa and luteal cells, and herein present preliminary evidence for the presence of a
transporter for ascorbic acid in human granulosa–lutein cells. Granulosa–lutein cells were obtained from the
follicular fluid of patients undergoing in-vitro fertilization. Following an overnight incubation, the cells
were incubated with [14C]-ascorbic acid (0.15 mCi; 150 mMM) and ascorbic acid uptake was determined. The
uptake of ascorbic acid was saturable with a Michaeli’s constant (Km) and maximum velocity (Vmax) of 21 mM
and 3 pmol/106 cells/min respectively. Ouabain, low Na1 medium, and dinitrophenol significantly inhibited
ascorbic acid uptake (P < 0.05). Neither the presence of insulin, human chorionic gonadotrophin (HCG), insulin-
like growth factor (IGF)-I, nor IGF-II affected the uptake of ascorbic acid in a statistically significant fashion.
Following saturation of cellular uptake, the ascorbic acid level was estimated to be 1.04 pmoles/106 cells or
~1 mM, a high concentration similar to that seen in rat luteal cells. Active ascorbic acid transport in human
granulosa–lutein cells appears to occur via a Na1- and energy-dependent transporter, with high levels of
ascorbic acid being accumulated in these cells.
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Introduction
Antioxidant vitamins are notable constituents of the ovary. In
particular, ascorbic acid is a water soluble and pre-eminent
scavenger of oxygen radicals and serves as an electron donor.
In animals, it has been shown that ascorbic acid is concentrated
in the granulosa and thecal cells of the follicle, as well as the
luteal cells of the corpus luteum and the peripheral cytoplasm
of the oocyte (Hoch-Ligeti and Bourne, 1948; Deane, 1952).
Ascorbic acid is produced by hepatic synthesis in species such
as rodents and domestic animals (Grollman and Lehninger,
1957; Levine and Morita, 1985); however, it must be available
in the diet of primates and guinea pigs. The vitamin is
then transported from blood into the peripheral tissues and
accumulated via membrane transporters against a large con-
centration gradient, most notably in the adrenal glands and the
gonads, which contain high concentrations of ascorbic acid
(Levine and Morita, 1985; Levine, 1986; Rose, 1988).
Tissue concentrations of ascorbic acid can be rapidly
depleted in response to hormones such as luteinizing hormone
(LH), prostaglandin (PG)F2α or PGE2, and this response is the
basis for a bioassay for some of these hormones (Sayers et al.,
1948; Parlow, 1972; Sato et al., 1974; Aten et al., 1992; Endo
et al., 1993). Work from our laboratory (Musicki et al., 1996)
has demonstrated that ascorbic acid depletion by LH in isolated
luteal cells occurred via an increase in ascorbic acid secretion,
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and that in-vivo depletion in the corpus luteum was blocked
by an inhibitor of steroidogenesis. PGF2α-induced ascorbic
acid depletion results from an inhibition of ascorbic acid
uptake into the cell, by stimulating cellular secretion, indicating
endocrine control of ascorbic acid concentrations in luteal cells
and the corpus luteum. Structural involution of the rat corpus
luteum is associated with a prolonged depletion of ascorbic
acid in association with induction of matrix-degrading enzymes
(Sato et al., 1974).
Similarly, the uptake of ascorbic acid in rat granulosa cells
was found to be hormonally regulated (Behrman et al.,
1996). Our work, together with previously reported findings
on the inhibition of apoptosis in granulosa cells by ascorbic
acid and other antioxidants (Tilly and Tilly, 1995), suggest
that ascorbic acid may play a vital role in the selection of the
dominant follicle and in the prevention of atresia or apoptosis
(Kramer et al., 1933; Tilly and Tilly, 1995; Tilly et al., 1995;
Behrman et al., 1996). No data, however, are available on the
presence of such transport mechanisms for ascorbic acid in
the human ovary, or on the total accumulation of ascorbic acid
in the human ovarian cell. The aim of the present studies
was, therefore, to examine ascorbic acid transport in human
granulosa–lutein cells and to determine whether such transport
is a constitutive or a hormonally-regulated process in human
ovarian cells.
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Materials and methods
Reagents
Human insulin-like growth factors (IGF)-I and IGF-II were acquired
from Collaborative Biomedical Products (Bedford, MA, USA) and
Sigma Chemical Company (St Louis, MO, USA) respectively. Insulin
was also purchased from Sigma, whereas human chorionic gonadotro-
phin (HCG) was obtained from Ayerst Laboratories (Rouses Point,
NY, USA). Penicillin, streptomycin, and fetal calf serum (FCS) were
acquired from Gibco (Grand Island, NY, USA), and all other chemical
reagents were obtained from Sigma. L-[1-14C]-ascorbic acid was
purchased from Amersham (Arlington Heights, IL, USA), and the
lyophilized trace was dissolved in 10 mM sodium phosphate buffer,
pH 5.0 and stored under argon at –20°C.
Acquisition and culture of human granulosa–lutein cells.
Granulosa–lutein cells were obtained from the follicular fluid of
patients undergoing in-vitro fertilization (IVF). The cells were
suspended in minimal essential medium (MEM) 1380 (Gibco) media
containing 0.1% bovine serum albumin (BSA), layered onto a Percoll
gradient and centrifuged for 30 min. The cells were then collected
from the interface and resuspended in media. CD450 magnetic beads
(Immunotech, ME, USA) were then used to remove the macrophages
and leukocytes (Best et al., 1994). Afterwards, the cells were
counted and plated in Dulbecco’s minimal essential medium (DMEM)/
F12 (Gibco) containing 1% FCS, at 106 cells/well in the presence of
100 IU/ml penicillin and 100 µg/ml streptomycin. The cells were
incubated overnight at 37°C, and ascorbic acid uptake was then
measured.
Ascorbic acid uptake
Prior to the measurement of ascorbic acid uptake, wells were
washed once with Hanks’ balanced salt solution (HBSS), pH 7.4,
supplemented with 0.5 mM thiourea and 0.1% BSA. Thiourea was
used to stabilize ascorbic acid and thus prevent its oxidation to
dehydroascorbic acid. All uptake experiments were carried out in this
medium to which [14C]-ascorbic acid (0.15 µCi; specific activity:
6.6–16.8 µCi/µmole) was added. Total ascorbate concentration varied
from 30–3000 µM and was adjusted by the addition of unlabelled
ascorbate. At the end of the uptake period, which ranged from
15–75 min, as indicated in the text, the culture dish was placed on
ice, and the cells were washed three times with 0.3 M sucrose,
as previously described (Musicki et al., 1996). The cells were
subsequently solubilized in 1 N NaOH for 30 min at 85°C and
then neutralized with 1 N HCl prior to assessment of intracellular
radioactivity by liquid scintillation counting. Non-specific back-
ground radioactivity was determined in identically treated, but
non-incubated, cells.
Uptake regulation studies
In the kinetic studies, granulosa cells were incubated overnight in
the absence of hormones. The cells were then exposed either to
dinitrophenol (1 mM) or low salt media for 10 min, or to 100 µM
ouabain for 75 min. Additional experiments were performed in which
the cells were preincubated for 48 h with insulin (10 nM), IGF-I or
IGF-II (50 ng/well), or HCG (1 IU/ml). The cells were then incubated
with [14C]-ascorbic acid (0.15 µCi; 150 µM) for 45 min. Intracellular
radioactivity was determined after washing the cells, and ascorbic
acid uptake was calculated as described above.
Viability analysis
Cell viability was determined by exclusion of Trypan Blue (Philips,
1973). After isolation of granulosa–lutein cells and enrichment as
described above, viability was ~85%.
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Figure 1. Time course of ascorbic acid uptake in human granulosa–
lutein cells. The mean 6 SEM of three replicate experiments are
shown. Granulosa–lutein cells were cultured for 24 h with no
hormone treatment. Uptake was determined as described the text.
Statistical analysis
Granulosa–lutein cells were pooled from several patients, and equal
aliquots were exposed to each treatment in triplicate. Each
experiment was repeated at least three times unless otherwise stated
in the text. Statistical significance between treatments in the three
replicate experiments was determined by one-way analysis of variance.
P , 0.05 was considered to be statistically significant.
Results
After a 24 h preculture period, human granulosa–lutein cells
accumulated [14C]-labelled ascorbic acid in a time- and cell-
dependent manner (Figure 1). Uptake was linear for 1 h
following the addition of ascorbate, and a period of 45 min
was chosen for further uptake experiments. Total accumulation
of ascorbic acid over a 3 h incubation period in human
granulosa–lutein cells was .1000 pmoles/106 or ~1 mM, a
magnitude similar to that seen in rat luteal cells (Musicki
et al., 1996). Figure 2 shows that ascorbic acid uptake
in cultured human granulosa–lutein cells was a substrate-
dependent and saturable process with a Michaeli’s constant
(Km) of 21 µM and a maximum velocity (Vmax) of 3 pmol/
106 cells/min.
Ascorbic acid uptake was noted to be energy-dependent, as
dinitrophenol (DNP), an inhibitor of mitochondrial proton
transport, or incubation at 4°C severely inhibited ascorbic acid
uptake (Figure 3). Ouabain (100 µM), an inhibitor of sodium/
potassium ATPase, also significantly inhibited ascorbic acid
uptake (P , 0.05); cytochalasin B, an agent that disrupts
microfilaments, had no significant effect (Figure 3). These
results indicate that the uptake of ascorbic acid by human
granulosa–lutein cells involves an active transport process that
depends on a sodium gradient established by the sodium/
potassium ATPase system, and also requires an intact cyto-
skeletal system.
Insulin (10 nM) and HCG (1 IU/ml) did not show a
statistically significant increase in ascorbic acid uptake
when compared with controls. IGF-I (50 ng/well) and IGF-II
(50 ng/well) showed no significant effect on ascorbic uptake
in human granulosa–lutein cells (Table I).
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Figure 2. Michaeli–Menton kinetics of ascorbic acid uptake in human granulosa–lutein cells. The mean 6 SEM of three independent
experiments are shown (see text for details).
Figure 3. Effect of inhibitors of sodium transport and energy
metabolism on ascorbic acid uptake by human granulosa–lutein
cells. Reduction of the transcellular Na1 gradient or uncoupling of
oxidative phosphorylation inhibits ascorbic acid uptake in granulosa
cells. The mean 6 SEM of three independent experiments are
shown.
Table I. Agents without effect on ascorbic acid uptake in human granulosa–
lutein cells
Treatment Percentage of control
Control 100 6 16.4
HCG 157.5 6 72.1
Insulin 156.4 6 31.0
IGF-I 117 6 5.2
IGF-II 116.3 6 5.1
HCG 5 human chorionic gonadotrophin; IGF 5 insulin-like growth factor.
Discussion
Reactive oxygen oxygen species (ROS) such as superoxide
anion (O2–) and hydrogen peroxide (H2O2) are generated under
a variety of biological conditions, most notably by phagocytic
leukocytes, endothelial cells, and fibroblasts. Ovulation and
luteal regression are marked by leukocytic infiltration, which
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is known to result in superoxide generation in quantities
sufficient to cause cell injury and death. Protection against
ROS is provided by scavenging ovarian antioxidants, most
notably ascorbic acid, which serves as an electron donor in
the scavenging of oxygen radicals and in the regeneration of
other vital oxidized agents, e.g. vitamin E and glutathione
(GSH) (Buettner, 1993; Frei, 1994; Meister, 1994).
A gradient of 20–100-fold exists between extracellular
(0.05 mM) and intracellular (1–5 mM) concentrations of
ascorbic acid in tissues, e.g. ovary, adrenal, brain, and leuko-
cytes, that contain very high values of this vitamin (Levine
and Morita, 1985). Such a concentration gradient implicates
that membrane transporters are necessary for the cellular
accumulation of ascorbic acid (Rose, 1988) as de-novo
synthesis occurs in the liver only. The cellular concentration
of ascorbic acid in the human ovary is not known as ascorbic
acid is rapidly depleted by the mere isolation of tissue
(Behrman, 1996; Musicki et al., 1996). Although the ascorbic
acid transporter has not been cloned, we have identified an
energy and Na1-dependent ascorbic acid transporter in rat
luteal and, more recently, rat granulosa cells (Behrman et al.,
1996; Musicki et al., 1996).
In the present study, we demonstrated that human granulosa–
lutein cells accumulated ascorbic acid in a time- and cell-
dependent manner. Uptake was a substrate-dependent and a
saturable process, with a Km and a Vmax of 21 µM and 3 pmol/
106cells/min respectively. As such, the human granulosa–lutein
cell ascorbic acid transport system showed characteristics
similar to those of transporters in other cells (Moger, 1987;
Rose, 1988; Musicki et al., 1996).
Ascorbic acid uptake in human granulosa–lutein cells was
also found to be driven by Na1- and energy-dependent trans-
porters, as ouabain an inhibitor of sodium/potassium ATPase,
and incubation of granulosa–lutein cells in a low Na1 medium
significantly inhibited ascorbic acid uptake. Similarly, DNP,
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an inhibitor of mitochondrial proton transport, significantly
inhibited ascorbic acid transport, which suggests that the
transport of ascorbic acid by human granulosa–lutein cells
involves an active process that depends on a sodium gradient
established by the Na1/K1 ATPase system. However, ascorbate
uptake was unaffected by HCG, insulin, IGF-I, or IGF-II
perhaps due to prior stimulation of these granulosa–lutein cells
at the time of IVF.
Ascorbic acid plays a vital role in follicular development
as scorbutic guinea pigs were shown to be anovulatory with
marked follicular degeneration and these animals also had
increased rates of implantation failure, and increased
spontaneous abortions (Kramer et al., 1933). More recent
studies have shown that ascorbic acid blocks apoptosis in
cultured follicles, which led Tilly and Tilly (1995) to the
conclusion that ascorbic acid and other antioxidants serve a role
to prevent atresia. More recent evidence from our laboratory
showed that ascorbic acid transport is up-regulated by follicle
stimulating hormone (FSH) and IGF-I (Behrman et al., 1996),
and that antioxidants block the spontaneous resumption of
meiosis in rat oocytes removed from the follicular environment
(M.Guarnacia et al., manuscript in preparation).
Interestingly, ascorbic acid supplementation increased the
ovulation inducing effects of clomiphene in anovulatory
women by an apparent local ovarian effect (Igarashi, 1997).
Beyond these studies, little information is available on the role
of ascorbic acid in human ovarian function although it has
been recently speculated to be a fertility enhancing factor
(Millar, 1992; Luck et al., 1995). In this study, we have
demonstrated the presence of an active ascorbic acid transport
mechanism in ovarian granulosa–luteal cells, which paves the
way for further studies on the role of ascorbic acid in follicular
development, ovulation, and luteal function in the human ovary.
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